Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Co-Investigator
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study.
Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice.
E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.
Co-Principal Investigator
See All 30 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Principal Investigator
Overview
researcher role of
Singh, Harinder
contributes to
Molecular and Cellular Biology Training